Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease 论文

2020Nature Medicine引用 441
DOI
Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Computational Drug Discovery MethodsCholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
相关技术:Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
关系图谱

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease · 相关文章

暂无数据